ShareValue scores for GPTHEALTH.NSE: Valuation 61, Quality 55, Growth 39, Health 50.

GPTHEALTH.NSE
NSE

GPT Healthcare Ltd

₹165.60(+0.55%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
61
Fair Value
Price vs Value
Quality
55
Moderate
Business Strength
Growth
39
Weak
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
59
Neutral
Price Trend

Company Details

About

GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026